Statement Of Financial Position [Abstract]

Ascelia Pharma - Filing #678716

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	89,000 SEK	—	—	—	—	—	—	163,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Right-of-use assets	973,000 SEK	—	—	—	—	—	—	462,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	57 074 SEK	—	—	—	—	—	—	57 074 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	21 855 SEK	—	—	—	—	—	—	149 555 SEK	—	—	—	—	—	—	—	—	261 599 SEK	—	—	—	—
Assets	87 072 SEK	—	—	—	—	—	—	218 569 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	34 871 SEK	—	—	—	—	—	—	34 871 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	639 962 SEK	—	—	—	—	—	—	533 732 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	74 328 SEK	—	—	—	—	—	—	180 859 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	74 328 SEK	639 962 SEK	- SEK	34 871 SEK	671,000 SEK	74 328 SEK	678 747 SEK	180 859 SEK	- SEK	533 732 SEK	34 871 SEK	972,000 SEK	180 859 SEK	678 747 SEK	405 827 SEK	678 831 SEK	307 834 SEK	307 834 SEK	- SEK	254,000 SEK	34 576 SEK
Liabilities [abstract]
Liabilities	12 744 SEK	—	—	—	—	—	—	37 711 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	87 072 SEK	—	—	—	—	—	—	218 569 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—